Yamazaki Kanami | Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
スポンサーリンク
概要
- YAMAZAKI Kanamiの詳細を見る
- 同名の論文著者
- Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researcの論文著者
関連著者
-
YAMORI Takao
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamori Takao
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer
-
Yamazaki Kanami
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Yamazaki Kanami
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yamori T
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yoshida Yoko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Dan Shingo
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Tsuruo Takashi
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
Yoshida Yoko
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
Dan Shingo
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Yoshida Yoko
Division Of Diabetes And Metabolism The Institute For Adult Diseases Asahi Life Foundation
-
SHIMADA KOJI
Department of Ocean Sciences, Faculty of Marine Science, Tokyo University of Marine Science and Tech
-
KUMADA KAORU
Department of Surgery, Showa University Fujigaoka Hospital
-
Nakamura Yusuke
Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of T
-
KANDA Hiroaki
Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research
-
Kanda H
Japanese Foundation For Cancer Res. Tokyo
-
TSURUO TAKASHI
Institute of Molecular and Cellular Biosciences, University of Tokyo
-
NAKATSU Noriyuki
Division of Cellular and Molecular Toxicology, BSRC, National Institute of Health Sciences
-
MAKUUCHI HIROYASU
Department of Cardiovascular Surgery, Tokai University Hospital
-
Kumada Kaoru
Department Of Human Living Tsukuba International Junior College
-
Kumada Kaoru
Department Of Surgery Fujigaoka Hospital Showa University
-
TSURUO Takashi
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
SADAHIRO Sotaro
Department of Surgery, Tokai University School of Medicine
-
Nakamura Tomoki
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
Sadahiro Soutaro
Second Department of Surgery, Tokai University School of Medicine
-
Makuuchi Hiroyasu
Second Department of Surgery, Tokai University School of Medicine
-
SHIRAKAWA Mieko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
MUKAI Yumiko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
KAWAGUCHI Tokuichi
Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research
-
MATSUURA Masaaki
Bioinformatics Group, Genome Center, Japanese Foundation for Cancer Research
-
NEMOTO Nobuo
Department of Experimental Pathology, Cancer Institute
-
中津 則之
東大院農
-
KOMI Akiko
Japanese Foundation for Cancer Research
-
Kong Dexin
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
NISHIZURU Yumiko
Division of Experimental Chemotherapy, Cancer Chemotherapy Center
-
KOMI Akiko
Division of Experimental Chemotherapy, Cancer Chemotherapy Center
-
ASANOMA Keiko
Division of Experimental Chemotherapy, Cancer Chemotherapy Center
-
OGAWA Masako
Division of Experimental Chemotherapy, Cancer Chemotherapy Center
-
NOMURA Kimie
Department of Pathology
-
Shimada Kazuaki
Hepatobiliary And Pancreatic Surgery Division National Cancer Center Hospital
-
ISHIZU Kazuhiro
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resea
-
SUNOSE Naohide
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
Nakamura Yusuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Makuuchi Hiroyasu
Department Of Cardiovascular Surgery Tokai University Hospital
-
Ishizu Kazuhiro
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Tsuruo Takashi
Institute Of Molecular And Cellular Biosciences The University Of Tokyo
-
Nemoto Nobuo
Department Of Experimental Pathology Cancer Institute
-
Nemoto Nobuo
Department Of Experimental Pathology Cancer Institute Japanese Foundation For Cancer Research
-
Mukai Y
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Kong Dexin
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Shimada Koji
Hepatobiliary And Pancreatic Surgery Division National Cancer Center Hospital
-
Kanda Hiroaki
Department Of Pathology
-
Kanda Hiroaki
Department Of Pathology Cancer Institute Hospital
-
Sunose Naohide
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
Sadahiro Sotaro
Department Of Surgery Tokai University School Of Medicine
-
Yamazaki Kanami
Div. Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Res.
-
Yamori Takao
Div. Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Res.
-
Nakamura Yusuke
Laboratory For Molecular Medicine Human Genome Center The Institute Of Medical Science University Of
-
Nakatsu Noriyuki
Division Of Cellular & Molecular Toxicology National Institute Of Health Sciences
-
Shimada Kazuaki
Heatobiliary Pancreatic Surgery Division National Cancer Center Hospital
-
Shirakawa Mieko
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
Kawaguchi Tokuichi
Department Of Cell Biology Japanese Foundation For Cancer Research Cancer Institute
-
Ogawa Masako
Division Of Experimental Chemotherapy Cancer Chemotherapy Center
-
Shimada Koji
Department Of Ocean Sciences Tokyo University Of Marine Science And Technology
-
Shimada Kazuaki
Division Of Hepato-biliary And Pancreatic Surgery National Cancer Center Hospital
-
Shimada Koji
Department Of Applied Chemistry And Biotechnology Faculty Of Engineering Yamanashi University
-
Matsuura Masaaki
Bioinformatics Group Genome Center Japanese Foundation For Cancer Research
-
Nakamura Yusuke
Laboratory For Genotyping Riken Snp Research Center C/o Riken Yokohama Institute
-
Nishizuru Yumiko
Division Of Experimental Chemotherapy Cancer Chemotherapy Center
-
Yamazaki Kanami
Division Of Molecular Pharmacology Cancer Chemotherapy Center Japanese Foundation For Cancer Researc
-
YOSHIDA Yoko
Sanuma Municipal General Hospital
-
Nakatsu Noriyuki
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Yoshida Yoko
Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
著作論文
- Discovery of Phosphatidylinositol 3-Kinase Inhibitory Compounds from the Screening Committee of Anticancer Drugs (SCADS) Library
- Identification of Candidate Genes Determining Chemosensitivity to Anti-cancer Drugs of Gastric Cancer Cell Lines
- Identification of candidate predictive markers of anticancer drug sensitivity using a panel of human cancer cell lines
- Establishment of a Hepatocyte Cell Line Producing Growth-promoting Factors for Liver-colonizing Tumor Cells
- Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116 Cells(Highlighted paper selected by Editor-in-chief,Miscellaneous)